Home Your basket
• Allergic and pneumologic ...
   Price 8.50 €
• Acoustic analysis of the ...
   Price 10.50 €
• Malignant mixed tumor of ...
   Price 5.50 €
• Somatic tinnitus (review)...
   Price 12.50 €
• Delayed facial palsy afte...
   Price 8.50 €
• Comparative results of ty...
   Price 10.50 €
• Unilateral endolymphatic ...
   Price 10.50 €
• Intrapetrous cholesteatom...
   Price 10.50 €
• Merkel cell carcinoma of ...
   Price 8.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• The place of the myocutan...
   Price 10.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Congenital anomalies of n...
   Price 14.00 €
• Tuberculous acute mastoid...
   Price 5.50 €
• A protocol for the evalua...
   Price 8.50 €
• Evaluation of the use of ...
   Price 8.50 €
• The application of tusso...
   Price 10.50 €
• Mycobacterial cervical ly...
   Price 10.50 €
• How to manage post staped...
   Price 5.50 €
• Proposition of adaptation...
   Price 10.50 €
• Use of inomeric cement: P...
   Price 10.50 €
• The EXIT procedure: Princ...
   Price 8.50 €
• The ENT in operations … T...
   Price 5.50 €
• Antro choanal polyp in ch...
   Price 10.00 €
• Bilateral vestibular loss...
   Price 10.50 €
• Kikuchi-Fujimoto’s diseas...
   Price 5.50 €
• Cervical liposuction: A r...
   Price 10.50 €
• Intra-orbital infected cy...
   Price 5.50 €
• Parathyroid carcinoma: di...
   Price 5.50 €
• Esophageal foreign body: ...
   Price 5.50 €
• A survey of current wound...
   Price 5.50 €
• Choanal atresia: therapeu...
   Price 10.50 €
• Cerebro-spinal fluid otor...
   Price 5.50 €
• Autologous fat graft for ...
   Price 14.00 €
• Central and peripherical ...
   Price 8.50 €
• Traditional and emerging ...
   Price 10.50 €
• Argon Plasma Coagulation ...
   Price 5.50 €
• Proposal of a rating scal...
   Price 10.50 €
• Tumours of the accessory ...
   Price 10.50 €
• Vocal rehabilitation with...
   Price 10.50 €
• Middle ear adenoma / carc...
   Price 8.50 €
• New technique of myringop...
   Price 5.50 €
• Diagnosis of non organic ...
   Price 8.50 €
• Thyroid oncocytomas....
   Price 10.50 €
• Iatrogenic scarring of th...
   Price 12.00 €
• Lipoma of the floor of th...
   Price 10.50 €
• Description of complicati...
   Price 5.50 €
• Otogenic pneumocephalus: ...
   Price 5.50 €
• Management of peritonsill...
   Price 5.50 €
• Virtual audiovisual talki...
   Price 10.50 €
• Benign tumors of the nasa...
   Price 14.00 €
• Carotid body paragangliom...
   Price 8.50 €
• Myringoplasties for anter...
   Price 10.50 €
• Pharyngeal pouch surgery ...
   Price 5.50 €
• The pedicle superficial t...
   Price 10.50 €
• Correlation between the r...
   Price 12.50 €
• Thyroid differenciated ca...
   Price 10.50 €
• A post-styloid mass revea...
   Price 12.50 €
• "Endolymphatic" cochleo-v...
   Price 10.50 €
• Functional anatomy of the...
   Price 14.00 €
• Cervical cystic lymphangi...
   Price 5.50 €
• Diagnosis management of W...
   Price 10.50 €
• A study of peristomal rec...
   Price 5.50 €
• A schwannoma of the hypog...
   Price 8.50 €
• Peptide receptor radionuc...
   Price 14.00 €
• Voice-breaking in adolesc...
   Price 10.50 €
• Fronto-ethmoidal fibrous ...
   Price 8.50 €
• Papillary carcinoma arisi...
   Price 5.50 €
• Validation of a self asse...
   Price 10.50 €
• Recovery of saccular func...
   Price 8.50 €

Total Order 631.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Download
o Issue N# 1 - 2000 o

OTONEUROLOGY

The natural history of untreated vestibular schwannomas. Is there a role for conservative management ?


Authors : R. M. Walsh, A. P. Bath, M. L. Bance, A. Keller, C. H. Tator, J. A. Rutka (Toronto)

Ref. : Rev Laryngol Otol Rhinol. 2000;121,1:21-26.

Article published in english



Summary : Objective: the aim of this study was to investigate the natural history and outcome following the conservative management of a group of patients with unilateral vestibular schwannomas. Methods: 72 patients with a radiological diagnosis of unilateral vestibular schwannoma were managed conservatively because of poor general health, advanced age, patient preference, small tumour size, minimal symptoms, or tumour in the only / better hearing ear. All patients underwent serial magnetic resonance imaging for assessment of tumour growth, according to American Academy of Otolaryngology-Head & Neck Surgery guidelines (1995). The mean duration of follow-up was 37.8 months (range 12-194 months). Patients were deemed to have failed conservative management if there was evidence of continuous or rapid radiological tumour growth, and / or increasing symptoms or signs. Results : the mean tumour growth rate was 1.16 mm/year (range -0.75 to 9.65 mm/year). Approximately 83% of tumours grew at less than 2 mm/year. Significant tumour growth (total growth > 1 mm) was seen in 36.4%, no or insignificant growth (0 - 1 mm) in 50%, and negative growth (< 0 mm) in 13.6% of tumours. The growth rate of cerebellopontine angle (CPA) tumours (1.4 mm/year) was significantly greater than that of tumours limited to the internal auditory canal (IAC) (0.2 mm/year) (p = 0.001). Failure of conservative management, in which active treatment was required, occurred in 15.3%. The outcome of these patients appeared to be as favourable as those who underwent primary treatment, without a period of conservative management. The growth rate of tumours in patients who failed conservative management (4.2 mm/year) was significantly greater than that in patients who did not fail (0.5 mm/year) (p < 0.01). No factors predictive of tumour growth were identified. Deterioration of mean pure tone average (0.5, 1, 2, 3 kHz) and speech discrimination scores occurred regardless of whether radiological tumour growth was demonstrated or not. Conclusions: The majority of vestibular schwannomas are slow growing, although, CPA tumours appear to grow faster than IAC tumours. Deterioration of auditory function occurs even in the absence of tumour growth. Although most Otolaryngologists and Neurosurgeons would agree that the treatment of choice for the majority of vestibular schwannomas is microsurgery, there remains a small group of patients in whom a conservative management approach may be a desirable alternative.


|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE